{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:50:55Z","timestamp":1786787455747,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Circulating microRNAs in the blood may provide diagnostic and prognostic information about canine neoplastic diseases, and their profiles may be conserved between human and canine species. We performed RT-qPCR to obtain the profiles of circulating plasma microRNA-214 and -126 in total 181 cases of canine neoplastic diseases and healthy controls. MicroRNA-214 levels were high in 2 epithelial tumours (thyroid and mammary carcinomas) and 4 non-epithelial tumours (osteosarcoma, histiocytic sarcoma, chondrosarcoma, and hemangiosarcoma). In contrast, microRNA-126 levels were high in 6 epithelial tumours (mammary, hepatocellular, squamous cell, thyroid, transitional cell carcinomas, and adenocarcinoma) and 4 non-epithelial tumours (osteosarcoma, mast cell tumour, melanoma, and hemangiosarcoma). The diagnostic potential of microRNA-214 was relatively high in sarcomas, whereas that of microR-126 was high in most types of the tumours. MicroRNA-214 and -126 were prognostic predictors in 2 groups (adenocarcinoma and non-epithelial tumours except for osteosarcoma) and 3 groups (epithelial tumours, adenocarcinoma, and melanoma), respectively. Additionally, the microRNA levels did not show a strong correlation with the other clinical parameters. In conclusion, circulating microRNA-214 and -126 have the potential to be diagnostic and prognostic biomarkers for canine neoplastic diseases. Furthermore, their profiles may be key references as well for exploring novel biomarkers for human cancers.<\/jats:p>","DOI":"10.1038\/s41598-017-02607-1","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T12:01:50Z","timestamp":1495022510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Kazuki","family":"Heishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Akao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"key":"2607_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0092-8674(89)90970-7","volume":"57","author":"S Benchimol","year":"1989","unstructured":"Benchimol, S., Fuks, A., Jothy, S. & Beauchemin, N. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell \n                           57, 327\u2013334, doi:10.1016\/0092-8674(89)90970-7 (1989).","journal-title":"Cell"},{"key":"2607_CR2","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM199306243282502","volume":"328","author":"Y Sato","year":"1993","unstructured":"Sato, Y. et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med \n                           328, 1802\u20131806, doi:10.1056\/NEJM199306243282502 (1993).","journal-title":"N Engl J Med"},{"key":"2607_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/vco.12052","volume":"13","author":"KA Selting","year":"2015","unstructured":"Selting, K. A., Sharp, C. R., Ringold, R. & Knouse, J. Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease. Vet Comp Oncol \n                           13, 373\u2013384, doi:10.1111\/vco.12052 (2015).","journal-title":"Vet Comp Oncol"},{"key":"2607_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nbt0906-1065b","volume":"24","author":"C Khanna","year":"2006","unstructured":"Khanna, C. et al. The dog as a cancer model. Nat Biotechnol \n                           24, 1065\u20131066 (2006).","journal-title":"Nat Biotechnol"},{"key":"2607_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.trsl.2011.11.005","volume":"159","author":"SS Pinho","year":"2012","unstructured":"Pinho, S. S., Carvalho, S., Cabral, J., Reis, C. A. & Gartner, F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res \n                           159, 165\u2013172, doi:10.1016\/j.trsl.2011.11.005 (2012).","journal-title":"Transl Res"},{"key":"2607_CR6","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1939-1676.2008.0133.x","volume":"22","author":"DF Merlo","year":"2008","unstructured":"Merlo, D. F. et al. Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. J Vet Intern Med \n                           22, 976\u2013984, doi:10.1111\/j.1939-1676.2008.0133.x (2008).","journal-title":"J Vet Intern Med"},{"key":"2607_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000362631","volume":"37","author":"P Schoffski","year":"2014","unstructured":"Schoffski, P., Cornillie, J., Wozniak, A., Li, H. & Hompes, D. Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease. Oncol Res Treat \n                           37, 355\u2013362, doi:10.1159\/000362631 (2014).","journal-title":"Oncol Res Treat"},{"key":"2607_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell \n                           116, 281\u2013297, doi:10.1016\/S0092-8674(04)00045-5 (2004).","journal-title":"Cell"},{"key":"2607_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","volume":"122","author":"CM Croce","year":"2005","unstructured":"Croce, C. M. & Calin, G. A. miRNAs, cancer, and stem cell division. Cell \n                           122, 6\u20137, doi:10.1016\/j.cell.2005.06.036 (2005).","journal-title":"Cell"},{"key":"2607_CR10","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich, A., Weiz, L., Langheinz, A. & Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic Acids Res \n                           39, 7223\u20137233, doi:10.1093\/nar\/gkr254 (2011).","journal-title":"Nucleic Acids Res"},{"key":"2607_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jhg.2016.87","volume":"62","author":"T Kinoshita","year":"2016","unstructured":"Kinoshita, T., Yip, K. W., Spence, T. & Liu, F. F. MicroRNAs in extracellular vesicles: potential cancer biomarkers. J Hum Genet \n                           62, 67\u201374, doi:10.1038\/jhg.2016.87 (2016).","journal-title":"J Hum Genet"},{"key":"2607_CR12","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","volume":"101","author":"N Kosaka","year":"2010","unstructured":"Kosaka, N., Iguchi, H. & Ochiya, T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci \n                           101, 2087\u20132092, doi:10.1111\/j.1349-7006.2010.01650.x (2010).","journal-title":"Cancer Sci"},{"key":"2607_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/dna.2006.0545","volume":"26","author":"CT Lee","year":"2007","unstructured":"Lee, C. T., Risom, T. & Strauss, W. M. Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol \n                           26, 209\u2013218, doi:10.1089\/dna.2006.0545 (2007).","journal-title":"DNA Cell Biol"},{"key":"2607_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-5590-1_1","volume":"774","author":"TA Farazi","year":"2013","unstructured":"Farazi, T. A., Hoell, J. I., Morozov, P. & Tuschl, T. MicroRNAs in human cancer. Adv Exp Med Biol \n                           774, 1\u201320, doi:10.1007\/978-94-007-5590-1_1 (2013).","journal-title":"Adv Exp Med Biol"},{"key":"2607_CR15","doi-asserted-by":"publisher","first-page":"e0137361","DOI":"10.1371\/journal.pone.0137361","volume":"10","author":"K Heishima","year":"2015","unstructured":"Heishima, K. et al. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis. PLoS One \n                           10, e0137361, doi:10.1371\/journal.pone.0137361 (2015).","journal-title":"PLoS One"},{"key":"2607_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1476-5829.2011.00306.x","volume":"11","author":"S Noguchi","year":"2013","unstructured":"Noguchi, S. et al. MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas. Vet Comp Oncol \n                           11, 113\u2013123, doi:10.1002\/vco.306 (2013).","journal-title":"Vet Comp Oncol"},{"key":"2607_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/fon.14.193","volume":"11","author":"T Sharma","year":"2015","unstructured":"Sharma, T., Hamilton, R. & Mandal, C. C. miR-214: a potential biomarker and therapeutic for different cancers. Future Oncol \n                           11, 349\u2013363, doi:10.2217\/fon.14.193 (2015).","journal-title":"Future Oncol"},{"key":"2607_CR18","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1100\/tsw.2010.198","volume":"10","author":"J Meister","year":"2010","unstructured":"Meister, J. & Schmidt, M. H. miR-126 and miR-126*: new players in cancer. Sci World J \n                           10, 2090\u20132100, doi:10.1100\/tsw.2010.198 (2010).","journal-title":"Sci World J"},{"key":"2607_CR19","doi-asserted-by":"publisher","first-page":"19589","DOI":"10.18632\/oncotarget.7319","volume":"7","author":"M Hao","year":"2016","unstructured":"Hao, M. et al. Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis. Oncotarget \n                           7, 19589\u201319600, doi:10.18632\/oncotarget.7319 (2016).","journal-title":"Oncotarget"},{"key":"2607_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/cam4.438","volume":"4","author":"W Allen-Rhoades","year":"2015","unstructured":"Allen-Rhoades, W. et al. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma. Cancer Med \n                           4, 977\u2013988, doi:10.1002\/cam4.438 (2015).","journal-title":"Cancer Med"},{"key":"2607_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10549-012-1988-6","volume":"134","author":"H Schwarzenbach","year":"2012","unstructured":"Schwarzenbach, H., Milde-Langosch, K., Steinbach, B., Muller, V. & Pantel, K. Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. Breast Cancer Res Treat \n                           134, 933\u2013941, doi:10.1007\/s10549-012-1988-6 (2012).","journal-title":"Breast Cancer Res Treat"},{"key":"2607_CR22","first-page":"821","volume":"5","author":"K-CC Zhang","year":"2015","unstructured":"Zhang, K.-C. C. et al. Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis. Am J Cancer Res \n                           5, 821\u2013829 (2015).","journal-title":"Am J Cancer Res"},{"key":"2607_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","volume":"110","author":"DD Taylor","year":"2008","unstructured":"Taylor, D. D. & Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol \n                           110, 13\u201321, doi:10.1016\/j.ygyno.2008.04.033 (2008).","journal-title":"Gynecol Oncol"},{"key":"2607_CR24","doi-asserted-by":"publisher","first-page":"e0153046","DOI":"10.1371\/journal.pone.0153046","volume":"11","author":"W Zhu","year":"2016","unstructured":"Zhu, W. et al. Diagnostic value of serum miR-182, miR-183, miR-210, and miR-126 levels in patients with early-stage non-small cell lung cancer. PLoS One \n                           11, e0153046, doi:10.1371\/journal.pone.0153046 (2016).","journal-title":"PLoS One"},{"key":"2607_CR25","doi-asserted-by":"publisher","first-page":"25377","DOI":"10.3390\/ijms161025377","volume":"16","author":"K Heishima","year":"2015","unstructured":"Heishima, K. et al. MicroRNA-214 and microRNA-126 are potential biomarkers for malignant endothelial proliferative diseases. Int J Mol Sci \n                           16, 25377\u201325391, doi:10.3390\/ijms161025377 (2015).","journal-title":"Int J Mol Sci"},{"key":"2607_CR26","doi-asserted-by":"publisher","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","volume":"39","author":"A Kozomara","year":"2011","unstructured":"Kozomara, A. & Griffiths-Jones, S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res \n                           39, D152\u2013157, doi:10.1093\/nar\/gkq1027 (2011).","journal-title":"Nucleic Acids Res"},{"key":"2607_CR27","doi-asserted-by":"publisher","first-page":"e41561","DOI":"10.1371\/journal.pone.0041561","volume":"7","author":"K Wang","year":"2012","unstructured":"Wang, K. et al. Comparing the MicroRNA spectrum between serum and plasma. PLoS One \n                           7, e41561, doi:10.1371\/journal.pone.0041561 (2012).","journal-title":"PLoS One"},{"key":"2607_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2144\/05382RR05","volume":"38","author":"V Luu-The","year":"2005","unstructured":"Luu-The, V., Paquet, N., Calvo, E. & Cumps, J. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques \n                           38, 287\u2013293, doi:10.2144\/05382rr05 (2005).","journal-title":"Biotechniques"},{"key":"2607_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbrc.2014.10.064","volume":"454","author":"M Xiang","year":"2014","unstructured":"Xiang, M. et al. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun \n                           454, 210\u2013214, doi:10.1016\/j.bbrc.2014.10.064 (2014).","journal-title":"Biochem Biophys Res Commun"},{"key":"2607_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ijc.25007","volume":"127","author":"Z Huang","year":"2010","unstructured":"Huang, Z. et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer \n                           127, 118\u2013126, doi:10.1002\/ijc.25007 (2010).","journal-title":"Int J Cancer"},{"key":"2607_CR31","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res \n                           10, 7252\u20137259, doi:10.1158\/1078-0432.CCR-04-0713 (2004).","journal-title":"Clin Cancer Res"},{"key":"2607_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7326\/0003-4819-104-1-66","volume":"104","author":"RH Fletcher","year":"1986","unstructured":"Fletcher, R. H. Carcinoembryonic antigen. Ann Intern Med \n                           104, 66\u201373, doi:10.7326\/0003-4819-104-1-66 (1986).","journal-title":"Ann Intern Med"},{"key":"2607_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0016-5085(86)90930-3","volume":"90","author":"WM Steinberg","year":"1986","unstructured":"Steinberg, W. M. et al. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology \n                           90, 343\u2013349, doi:10.1016\/0016-5085(86)90930-3 (1986).","journal-title":"Gastroenterology"},{"key":"2607_CR34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4149\/neo_2012_064","volume":"59","author":"X Li","year":"2012","unstructured":"Li, X. et al. Biomarkers in the lung cancer diagnosis: a clinical perspective. Neoplasma \n                           59, 500\u2013507, doi:10.4149\/neo_2012_064 (2012).","journal-title":"Neoplasma"},{"key":"2607_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cca.2008.05.010","volume":"395","author":"EN Debruyne","year":"2008","unstructured":"Debruyne, E. N. & Delanghe, J. R. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta \n                           395, 19\u201326, doi:10.1016\/j.cca.2008.05.010 (2008).","journal-title":"Clin Chim Acta"},{"key":"2607_CR36","doi-asserted-by":"publisher","first-page":"e86149","DOI":"10.1371\/journal.pone.0086149","volume":"9","author":"ZC Zhang","year":"2014","unstructured":"Zhang, Z. C. et al. Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PLoS One \n                           9, e86149, doi:10.1371\/journal.pone.0086149 (2014).","journal-title":"PLoS One"},{"key":"2607_CR37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/bjc.2016.234","volume":"115","author":"KS Chandrasekaran","year":"2016","unstructured":"Chandrasekaran, K. S., Sathyanarayanan, A. & Karunagaran, D. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells. Br J Cancer \n                           115, 741\u2013751, doi:10.1038\/bjc.2016.234 (2016).","journal-title":"Br J Cancer"},{"key":"2607_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1159\/000443036","volume":"38","author":"L Yang","year":"2016","unstructured":"Yang, L. et al. MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1. Cell Physiol Biochem \n                           38, 809\u2013820, doi:10.1159\/000443036 (2016).","journal-title":"Cell Physiol Biochem"},{"key":"2607_CR39","doi-asserted-by":"publisher","unstructured":"van Balkom, B. W. et al. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood \n                           121, 3997\u20134006, S3991\u20133915, doi:10.1182\/blood-2013-02-478925 (2013).","DOI":"10.1182\/blood-2013-02-478925"},{"key":"2607_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13577-014-0105-z","volume":"28","author":"C Zhao","year":"2015","unstructured":"Zhao, C., Li, Y., Zhang, M., Yang, Y. & Chang, L. miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2. Hum Cell \n                           28, 91\u201399, doi:10.1007\/s13577-014-0105-z (2015).","journal-title":"Hum Cell"},{"key":"2607_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1476-4598-13-169","volume":"13","author":"S Taverna","year":"2014","unstructured":"Taverna, S. et al. Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells. Mol Cancer \n                           13, 169, doi:10.1186\/1476-4598-13-169 (2014).","journal-title":"Mol Cancer"},{"key":"2607_CR42","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.2147\/OTT.S112358","volume":"9","author":"J Xiao","year":"2016","unstructured":"Xiao, J., Lin, H. Y., Zhu, Y. Y., Zhu, Y. P. & Chen, L. W. MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K\/Akt signaling pathway. Onco Targets Ther \n                           9, 5181\u20135193, doi:10.2147\/OTT.S105198 (2016).","journal-title":"Onco Targets Ther"},{"key":"2607_CR43","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.4161\/rna.21083","volume":"9","author":"A Turchinovich","year":"2012","unstructured":"Turchinovich, A. & Burwinkel, B. D. AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol \n                           9, 1066\u20131075, doi:10.4161\/rna.21083 (2012).","journal-title":"RNA Biol"},{"key":"2607_CR44","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1182\/blood-2010-09-299719","volume":"117","author":"S Nagalla","year":"2011","unstructured":"Nagalla, S. et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood \n                           117, 5189\u20135197, doi:10.1182\/blood-2010-09-299719 (2011).","journal-title":"Blood"},{"key":"2607_CR45","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3390\/jcm4121957","volume":"4","author":"SR Pfeffer","year":"2015","unstructured":"Pfeffer, S. R. et al. Detection of exosomal miRNAs in the plasma of melanoma patients. J Clin Med \n                           4, 2012\u20132027, doi:10.3390\/jcm4121957 (2015).","journal-title":"J Clin Med"},{"key":"2607_CR46","doi-asserted-by":"publisher","first-page":"e102382","DOI":"10.1371\/journal.pone.0102382","volume":"9","author":"D Dai","year":"2014","unstructured":"Dai, D. et al. Serum miRNA signature in Moyamoya disease. PLoS One \n                           9, e102382, doi:10.1371\/journal.pone.0102382 (2014).","journal-title":"PLoS One"},{"key":"2607_CR47","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1038\/srep05026","volume":"4","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y. et al. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep \n                           4, 5026, doi:10.1038\/srep05026 (2014).","journal-title":"Sci Rep"},{"key":"2607_CR48","doi-asserted-by":"publisher","first-page":"10567","DOI":"10.3390\/ijms150610567","volume":"15","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci \n                           15, 10567\u201310577, doi:10.3390\/ijms150610567 (2014).","journal-title":"Int J Mol Sci"},{"key":"2607_CR49","doi-asserted-by":"publisher","first-page":"35372","DOI":"10.18632\/oncotarget.6164","volume":"6","author":"F Olivieri","year":"2015","unstructured":"Olivieri, F. et al. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications. Oncotarget \n                           6, 35372\u201335382, doi:10.18632\/oncotarget.6164 (2015).","journal-title":"Oncotarget"},{"key":"2607_CR50","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jaci.2016.01.029","volume":"137","author":"RP Panganiban","year":"2016","unstructured":"Panganiban, R. P. et al. Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma. J Allergy Clin Immunol \n                           137, 1423\u20131432, doi:10.1016\/j.jaci.2016.01.029 (2016).","journal-title":"J Allergy Clin Immunol"},{"key":"2607_CR51","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1590\/1414-431X20154590","volume":"48","author":"XJ Wei","year":"2015","unstructured":"Wei, X. J. et al. Biological significance of miR-126 expression in atrial fibrillation and heart failure. Braz J Med Biol Res \n                           48, 983\u2013989, doi:10.1590\/1414-431X20154590 (2015).","journal-title":"Braz J Med Biol Res"},{"key":"2607_CR52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3969\/j.issn.1671-5411.2013.01.007","volume":"10","author":"HQ Lu","year":"2013","unstructured":"Lu, H. Q., Liang, C., He, Z. Q., Fan, M. & Wu, Z. G. Circulating miR-214 is associated with the severity of coronary artery disease. J Geriatr Cardiol \n                           10, 34\u201338, doi:10.3969\/j.issn.1671-5411.2013.01.007 (2013).","journal-title":"J Geriatr Cardiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02607-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02607-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02607-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:31:59Z","timestamp":1671769919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02607-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2607"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-02607-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]},"assertion":[{"value":"2 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2301"}}